ARMI's BioFab Startup Lab
Building and Connecting the Regenerative Manufacturing Ecosystem
The BioFab Startup Lab, launched through a grant from the U.S. Economic Development Administration, offers newly formed and emerging companies an opportunity to translate biotechnology innovation into commercial products. The Startup Lab aims to accelerate the time-to-market of regenerative medicine therapies and enabling biomanufacturing technologies for U.S. based companies.
Applications for Cohort 3 are now open through March 17, 2025 – apply now!
Comprehensive Services to Drive Innovation
We are a team of entrepreneurs, scientists, engineers, investors, and operators who actively work alongside startups to help them grow and succeed.
The ARMI ecosystem is a hub of top-tier experts in regenerative manufacturing, offering startups access to cutting-edge knowledge and resources. Through the BioFab Startup Lab, early-stage startups can collaborate with these experts, benefiting from their guidance as consultants, advisors, and fractional team members.
ARMI’s network of resources offers a broad range of expertise, including:
- Market and customer research and competitive landscape analysis
- Regulatory and quality review, development, and execution
- Manufacturing, commercialization, and clinical adoption
- Financial modeling, reimbursement, payment, and value generation models
- Legal support and IP strategy
- Pitch development, refinement, and storytelling
- Executing coaching, leadership and team building
- Marketing, communications, and brand development
- Back-office and administrative support
These comprehensive capabilities help startups navigate challenges and accelerate growth, ultimately delivering on the promise of regenerative manufacturing.
